APA (7th ed.) Citation

Pratley, R. E., Husain, M., Lingvay, I., Pieber, T. R., Mark, T., Saevereid, H. A., . . . Zinman, B. (2019). Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14. Cardiovascular Diabetology, 18(1), 1. https://doi.org/10.1186/s12933-019-0960-8

Chicago Style (17th ed.) Citation

Pratley, Richard E., Mansoor Husain, Ildiko Lingvay, Thomas R. Pieber, Thomas Mark, Hans A. Saevereid, Daniel Vega Møller, and Bernard Zinman. "Heart Failure with Insulin Degludec Versus Glargine U100 in Patients with Type 2 Diabetes at High Risk of Cardiovascular Disease: DEVOTE 14." Cardiovascular Diabetology 18, no. 1 (2019): 1. https://doi.org/10.1186/s12933-019-0960-8.

MLA (9th ed.) Citation

Pratley, Richard E., et al. "Heart Failure with Insulin Degludec Versus Glargine U100 in Patients with Type 2 Diabetes at High Risk of Cardiovascular Disease: DEVOTE 14." Cardiovascular Diabetology, vol. 18, no. 1, 2019, p. 1, https://doi.org/10.1186/s12933-019-0960-8.